Cargando…

Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine

Detalles Bibliográficos
Autores principales:	Ahmed, F, Khalil, M, Quarshie, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620140/ http://dx.doi.org/10.1186/1129-2377-14-S1-P187

Ejemplares similares

EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
por: Khalil, M, et al.
Publicado: (2014)

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
por: Khalil, Modar, et al.
Publicado: (2014)

EHMTI-0090. Botox in the prevention of chronic migraine; comparing NICE criteria versus hull criteria for evaluating responder rate
por: Zafar, H, et al.
Publicado: (2014)

P042. Mechanism of action and clinical evidence of botulinum toxin in chronic migraine
por: Franco, Giovanni, et al.
Publicado: (2015)

Effect of Botulinum Toxin type-A (Botox(®)) on neck pain and craniocervical headaches caused by trapezius spasm in a child with generalised joint hypermobility resulting from Noonan's Syndrome
por: Tofts, LJ, et al.
Publicado: (2008)

P005. Efficacy Type-A Botulinum toxin treatment in a multidisciplinary setting for chronic headache
por: Vescio, Giuseppe, et al.
Publicado: (2015)

Bilateral jaw dislocation following botulinim toxin type A treatment for chronic migraine
por: Forbes, RB, et al.
Publicado: (2013)

O048. Chronic migraine, cluster headache or both? The suggestion of botulinum toxin
por: Ripa, Patrizia, et al.
Publicado: (2015)

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience
por: Farinelli, I., et al.
Publicado: (2006)

O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
por: Ornello, Raffaele, et al.
Publicado: (2015)

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

Dispute settlement understanding on the use of BOTOX(®) in chronic migraine
por: Martelletti, Paolo
Publicado: (2011)

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Turkel, Catherine C., et al.
Publicado: (2023)

An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions
por: Persaud, Ricardo, et al.
Publicado: (2013)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

EHMTI-0223. Botox in the prevention of chronic migraine; 18-months follow up outcome in 67 patients
por: Khalil, M, et al.
Publicado: (2014)

The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions – An evidence based review
por: Awan, Kamran Habib
Publicado: (2017)

P009. A case of new daily persistent headache treated with botulinum toxin type A
por: Trucco, Marco, et al.
Publicado: (2015)

The effects of botulinum toxin type A on the trigeminal TRPV1 containing neurons innervating the dura mater of rat
por: Shimizu, T, et al.
Publicado: (2013)

EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse
por: Zafar, H, et al.
Publicado: (2014)

Convex-hull voting method on a large data set
por: Ellingson, Sally R, et al.
Publicado: (2015)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
por: Kępczyńska, Katarzyna, et al.
Publicado: (2022)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect
por: Satriyasa, Bagus Komang
Publicado: (2019)

Botox, Migraine, and the American Academy of Neurology: An Antidote to Anecdote
por: Jackson, Mark, et al.
Publicado: (2008)

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
por: Shaterian, Negar, et al.
Publicado: (2022)

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
por: Oterino, A., et al.
Publicado: (2011)

Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials
por: Shao, Yu-Feng, et al.
Publicado: (2013)

Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study
por: Barrientos, Nelson, et al.
Publicado: (2003)

A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
por: Kim, Young-gun, et al.
Publicado: (2020)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN(®)) Botulinum Toxin in Chronic Refractory Migraine
por: Ion, Ioana, et al.
Publicado: (2018)

Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012)

Tension type headache is dead; long live chronic migraine!
por: Elrington, GE
Publicado: (2013)

Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
por: Naderinabi, Bahram, et al.
Publicado: (2017)

EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine
por: Bergmans, BA, et al.
Publicado: (2014)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
por: Hansson-Hedblom, Amanda, et al.
Publicado: (2020)

Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study
por: Sebastianelli, Gabriele, et al.
Publicado: (2023)

Beyond Beauty: Onobotulinumtoxin A (BOTOX®) and the Management of Migraine Headaches
por: Becker, Devra, et al.
Publicado: (2012)

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
por: Robertson, Carrie E, et al.
Publicado: (2012)

Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker
por: Bumb, Anja, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u4lt573jcmck4g3t357tk3ad9j